102 results on '"Rust, Alistair G."'
Search Results
2. Supplementary Data from Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis
3. Data from Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis
4. Supplementary Data from Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis
5. Supplementary Data from Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis
6. Supplementary Data from Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis
7. Supplementary Data from Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis
8. Supplementary Data from Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis
9. Supplementary Data from Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis
10. Supplementary Data from Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis
11. Supplementary Data from Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis
12. Supplementary Figure 2 from Loss of Rassf1a Synergizes with Deregulated Runx2 Signaling in Tumorigenesis
13. Data from Loss of Rassf1a Synergizes with Deregulated Runx2 Signaling in Tumorigenesis
14. Data from Loss of Rassf1a Synergizes with Deregulated Runx2 Signaling in Tumorigenesis
15. Data from Identification of FoxR2 as an Oncogene in Medulloblastoma
16. Supplementary Tables 1-5 from Novel Candidate Cancer Genes Identified by a Large-Scale Cross-Species Comparative Oncogenomics Approach
17. Supplementary Figure 1 from Loss of Rassf1a Synergizes with Deregulated Runx2 Signaling in Tumorigenesis
18. Supplementary Table 7 from Novel Candidate Cancer Genes Identified by a Large-Scale Cross-Species Comparative Oncogenomics Approach
19. Supplementary Table 2 from Loss of Rassf1a Synergizes with Deregulated Runx2 Signaling in Tumorigenesis
20. Supplementary Table 7 from Novel Candidate Cancer Genes Identified by a Large-Scale Cross-Species Comparative Oncogenomics Approach
21. Supplementary Tables 1-5 from Novel Candidate Cancer Genes Identified by a Large-Scale Cross-Species Comparative Oncogenomics Approach
22. Data from Identification of FoxR2 as an Oncogene in Medulloblastoma
23. Supplementary Figure 1, Table 1 from Identification of FoxR2 as an Oncogene in Medulloblastoma
24. Supplementary Methods from Novel Candidate Cancer Genes Identified by a Large-Scale Cross-Species Comparative Oncogenomics Approach
25. Supplementary Table 1 from Loss of Rassf1a Synergizes with Deregulated Runx2 Signaling in Tumorigenesis
26. Supplementary Methods from Novel Candidate Cancer Genes Identified by a Large-Scale Cross-Species Comparative Oncogenomics Approach
27. Supplementary Figure 2 from Loss of Rassf1a Synergizes with Deregulated Runx2 Signaling in Tumorigenesis
28. Data from Novel Candidate Cancer Genes Identified by a Large-Scale Cross-Species Comparative Oncogenomics Approach
29. Data from Novel Candidate Cancer Genes Identified by a Large-Scale Cross-Species Comparative Oncogenomics Approach
30. Supplementary Table 6 from Novel Candidate Cancer Genes Identified by a Large-Scale Cross-Species Comparative Oncogenomics Approach
31. Supplementary Table 6 from Novel Candidate Cancer Genes Identified by a Large-Scale Cross-Species Comparative Oncogenomics Approach
32. Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis
33. "Transposon Mutagenesis Reveals RBMS3 as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis."
34. Engineering Cancer Antigen-Specific T Cells to Overcome the Immunosuppressive Effects of TGF-β
35. Mutational Genomics for Cancer Pathway Discovery
36. Using Varying Negative Examples to Improve Computational Predictions of Transcription Factor Binding Sites
37. Improving Transcription Factor Binding Site Predictions by Using Randomised Negative Examples
38. Effect of Using Varying Negative Examples in Transcription Factor Binding Site Predictions
39. Using Real-Valued Meta Classifiers to Integrate and Contextualize Binding Site Predictions
40. Evolving computational neural systems using synthetic developmental mechanisms
41. Contributors
42. Towards Computational Neural Systems through Developmental Evolution
43. Developmental Evolution of an Edge Detecting Retina
44. Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
45. Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
46. A lentiviral vector‐based insertional mutagenesis screen identifies mechanisms of resistance to MAPK inhibitors in melanoma
47. Optimised ARID1A immunohistochemistry is an accurate predictor ofARID1Amutational status in gynaecological cancers
48. Capture Hi-C identifies putative target genes at 33 breast cancer risk loci
49. Transposon mutagenesis identifies genes that cooperate with mutant Pten in breast cancer progression
50. Analyzing tumor heterogeneity and driver genes in single myeloid leukemia cells with SBCapSeq
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.